Involvement of Calmodulin and Calmodulin Binding Site in the TSH Receptor of Thyroid

4Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Calmodulin (CaM) antagonists, W-7 and W-5, chlorpromazine and haloperidol, especially W-7 inhibited 125I-bovine TSH binding to human and porcine thyroid receptors dose-dependently in the presence of calcium ion. This inhibitory effect of W-7 was diminished by the addition of ethylenglycol tetraacetic acid (EGTA) or ethylendiamine tetraacetic acid (EDTA). CaM also dose-dependently inhibited the binding of 125I-TSH to thyroid receptor in the presence of calcium ion. TSH binding to thyroid receptor was completely inhibited by more than 30 pg of CaM, and this inhibition was abolished by adding EGTA. On the other hand, the antibody to CaM inhibited partially 125I-TSH binding to its receptor. These results suggest involvement of CaM and CaM-binding sites in the TSH receptor of thyroid. © 1987, The Japan Endocrine Society. All rights reserved.

Cite

CITATION STYLE

APA

Nakajima, Y., Kajita, Y., Ishida, M., Ura, Y., Ochi, Y., Hachiya, T., & Hidaka, H. (1987). Involvement of Calmodulin and Calmodulin Binding Site in the TSH Receptor of Thyroid. Endocrinologia Japonica, 34(4), 505–511. https://doi.org/10.1507/endocrj1954.34.505

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free